463 related articles for article (PubMed ID: 9570512)
21. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
22. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1.
Naghavi MH; Schwartz S; Sönnerborg A; Vahlne A
AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1293-303. PubMed ID: 10505678
[TBL] [Abstract][Full Text] [Related]
23. Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.
Estable MC; Bell B; Hirst M; Sadowski I
J Virol; 1998 Aug; 72(8):6465-74. PubMed ID: 9658089
[TBL] [Abstract][Full Text] [Related]
24. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
Swingler S; Easton A; Morris A
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
[TBL] [Abstract][Full Text] [Related]
25. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat.
Zhang Y; Nakata K; Weiden M; Rom WN
J Clin Invest; 1995 May; 95(5):2324-31. PubMed ID: 7738195
[TBL] [Abstract][Full Text] [Related]
26. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
27. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.
Hogan TH; Stauff DL; Krebs FC; Gartner S; Quiterio SJ; Wigdahl B
J Neurovirol; 2003 Feb; 9(1):55-68. PubMed ID: 12587069
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
Chang LJ; McNulty E; Martin M
J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
[TBL] [Abstract][Full Text] [Related]
29. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
[TBL] [Abstract][Full Text] [Related]
30. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.
Giacca M; Gutierrez MI; Menzo S; d'Adda di Fagagna F; Falaschi A
Virology; 1992 Jan; 186(1):133-47. PubMed ID: 1727595
[TBL] [Abstract][Full Text] [Related]
31. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
Zeichner SL; Kim JY; Alwine JC
J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
[TBL] [Abstract][Full Text] [Related]
32. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific.
Hogan TH; Nonnemacher MR; Krebs FC; Henderson A; Wigdahl B
Biomed Pharmacother; 2003 Jan; 57(1):41-8. PubMed ID: 12642036
[TBL] [Abstract][Full Text] [Related]
34. Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.
Ross EK; Buckler-White AJ; Rabson AB; Englund G; Martin MA
J Virol; 1991 Aug; 65(8):4350-8. PubMed ID: 2072454
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells.
Atwood WJ; Tornatore CS; Traub R; Conant K; Drew PD; Major EO
AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1207-11. PubMed ID: 7848678
[TBL] [Abstract][Full Text] [Related]
36. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
37. Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.
Shah S; Alexaki A; Pirrone V; Dahiya S; Nonnemacher MR; Wigdahl B
Virol J; 2014 May; 11():92. PubMed ID: 24886416
[TBL] [Abstract][Full Text] [Related]
38. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
39. Modulation of HIV transcription by CD8(+) cells is mediated via multiple elements of the long terminal repeat.
Maslove DM; Ni LW; Hawley-Foss NC; Badley AD; Copeland KF
Clin Exp Immunol; 2001 Jul; 125(1):102-9. PubMed ID: 11472432
[TBL] [Abstract][Full Text] [Related]
40. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
